75A50124C00033
Definitive Contract
Overview
Government Description
The development of antimicrobials for the treatment of resistant fungal and bacterial infections - OTA. Includes research and development activities for medical countermeasures (MCM) targeting Chemical, Biological, Radiological, And Nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases. Advanced development activities focus on mcms for influenza and other emerging respiratory viruses, as well as capabilities in modeling, visual analytics, and early notification to support barda’s product development work.
Awarding / Funding Agency
Place of Performance
Switzerland
Pricing
Cost Sharing
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
111
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential Award value has decreased 6% from $267,582,260 to $252,093,994.
Basilea Pharmaceutica International Ltd, Allschwil was awarded
Definitive Contract 75A50124C00033 (75A501-24-C-00033)
for Development Of Antimicrobials For Resistant Fungal And Bacterial Infections - OTA
worth up to $252,093,994
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2024.
The contract
has a duration of 11 years 3 months and
was awarded
through solicitation Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
full & open
with
NAICS 541714 and
PSC AN42
via direct negotiation acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $129,592,762.
Status
(Open)
Last Modified 7/28/26
Period of Performance
9/30/24
Start Date
3/31/32
Current End Date
12/31/35
Potential End Date
Obligations and Backlog
$122.5M
Total Obligated
$122.5M
Current Award
$252.1M
Potential Award
$0.0
Funded Backlog
$129.6M
Total Backlog
Award Hierarchy
Definitive Contract
75A50124C00033
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for 75A50124C00033
Transaction History
Modifications to 75A50124C00033
People
Suggested agency contacts for 75A50124C00033
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
UA43HWRNXFS3
Awardee CAGE
SSU10
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
750501
Created By
hhsrichard_hall
Last Modified By
hhsjonathan_gonzalez
Approved By
hhsjonathan_gonzalez
Legislative
Legislative Mandates
None Applicable
Performance District
Not Applicable
Modified: 7/28/26